1,769
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems

, PhD, MPH, , DrPH, MSW, , MD, MPH, MS, , PhD, MPH, MSW, , PhD, LMSW, , PsyD, , PhD, MS, , PhD, , MD, PhD, , PhD & , MS show all

References

  • Han B, Compton WM, Jones CM, Cai R. Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003-2013. JAMA. 2015;314(14):1468–1478.
  • U.S. Department of Health and Human Services and Office of the Surgeon General. Facing Addiction in America: the Surgeon General’s Report on Alcohol, Drugs, and Health. Washington, DC: U.S. Department of Health & Human Services; 2016.
  • Centers for Disease Control and Prevention and National Center for Injury Prevention and Control. Opioid overdose. https://www.cdc.gov/drugoverdose/index.html. Published October 23 2017. Accessed Mar 6, 2018.
  • Guy GP, Jr., Zhang K, Bohm MK, et al. Vital Signs: Changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66(26):697–704.
  • O'Donnell JK, Halpin J, Mattson CL, Goldberger BA, Gladden RM. Deaths involving fentanyl, fentanyl analogs, and U-47700 - 10 states, July-December 2016. MMWR Morb Mortal Wkly Rep. 2017;66(43):1197–1202.
  • Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths - United States, 2010-2015. MMWR Morb Mortal Wkly Rep. 2016;65(50-51):1445–1452.
  • McCarty D, Priest KC, Korthuis PT. Treatment and prevention of opioid use disorder: challenges and opportunities. Annu Rev Public Health. 2018;39:525–541.
  • Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2016 National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; HHS Publication No. SMA 17- 044, NSDUH Series H-52. https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2016/NSDUH-FFR1-2016.pdf. Published 2017. Accessed August 9, 2018.
  • National Committee for Quality Assurance. HEDIS 2015 QRS Technical Update. Washington (DC): National Committee for Quality Assurance (NCQA); http://www.ncqa.org/Portals/0/HEDISQM/Hedis2015/HEDIS%20QRS%202015%20Technical% 20Update_Final.pdf. Published October 1 2014. Accessed July 26, 2018.
  • Harris AHS, Humphreys K, Finney JW. Veterans Affairs facility performance on Washington Circle indicators and casemix-adjusted effectiveness. J Subst Abuse Treat. 2007;33(4):333–339.
  • National Committee for Quality Assurance. Initiation and Engagement of Alcohol and Other Drug Dependence Treatment. This HEDIS measure. http://www.ncqa.org/report-cards/health-plans/state-of-health-care-quality/2017-table-of-contents/alcohol-treatment. Published 2017. Accessed May 6, 2018.
  • Weisner C, Campbell CI, Altschuler A, et al. Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) Alcohol and Other Drug (AOD) measure performance in 2014-2015. Subst Abus. https://www.tandfonline.com/wsub. Published 2019.
  • Yarborough BJH, Chi FW, Green CA, et al. Patient and system characteristics associated with performance on the HEDIS measures of Alcohol and Other Drug Treatment Initiation and Engagement. J Addict Med. 2018; 12(4):278–286.
  • Ross TR, Ng D, Brown JS, et al. The HMO Research Network Virtual Data Warehouse: a public data model to support collaboration. EGEMS (Wash DC). 2014;2(1):1049.
  • Agency for Healthcare Research and Quality. Engagement of alcohol and other drug (AOD) treatment: percentage of members who initiated treatment and who had two or more additional services with a diagnosis of AOD within 30 days of the initiation visit. National Quality Measures Clearinghouse 2015. https://www.qualitymeasures.ahrq.gov/summaries/summary/49778. Published October Accessed June 21, 2018.
  • National Committee for Quality Assurance. Summary table of measures, product lines and changes. HEDIS 2015;2:8. http://www.ncqa.org/Portals/0/HEDISQM/Hedis2015/List_of_HEDIS_2015_Measures.pdf. Published 2015. Accessed July 26, 2018.
  • Sikkink J, Fleming MF. Adverse health effects and medical complications of alcohol, nicotine, and drug abuse. In: Fleming MF and Barry KL eds. Addictive Disorders: A Practical Guide to Treatment. St. Louis: Mosby-Year Book Primary Care Series; 1992:145–168.
  • Stein MD. Medical consequences of substance abuse. Psychiatr Clin North Am. 1999;22(2):351–370.
  • Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA. 2001;286(14):1715–1723.
  • Levy B, Paulozzi L, Mack KA, Jones CM. Trends in opioid analgesic-prescribing rates by specialty, U.S., 2007-2012. Am J Prev Med. 2015;49(3):409–413.
  • D'Onofrio G, Chawarski MC, O'Connor PG, et al. Emergency Department-initiated buprenorphine for opioid dependence with continuation in primary care: Outcomes during and after intervention. J Gen Intern Med. 2017;32(6):660–666.
  • Alford DP, LaBelle CT, Kretsch N, et al. Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience. Arch Intern Med. 2011;171(5):425–431.
  • Ronan MV, Herzig SJ. Hospitalizations related to opioid abuse/dependence and associated serious infections increased sharply, 2002-12. Health Aff (Millwood). 2016;35(5):832–837.
  • Englander H, Weimer M, Solotaroff R, et al. Planning and Designing the Improving Addiction Care Team (IMPACT) for hospitalized adults with substance use disorder. J Hosp Med. 2017;12(5):339–342.
  • Wakeman SE, Metlay JP, Chang Y, Herman GE, Rigotti NA. Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity. J Gen Intern Med. 2017;32(8):909–916.